{"url_path":"/sec/rmtg/10-q/2026/item-3","section_key":"item-3","section_title":"Item 3 Defaults Upon Senior Securities**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-09","source_url":"https://www.sec.gov/Archives/edgar/data/1760026/0001213900-26-066838-index.html","accession_number":"0001213900-26-066838","cik":"0001760026","ticker":"RMTG","issuer_name":"Regenerative Medical Technology Group Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1760026/0001213900-26-066838-index.html","primary_entity_key":"0001760026","primary_entity_name":"Regenerative Medical Technology Group Inc."},"word_count":578,"has_tables":true,"body_markdown":"**Item 3. Defaults Upon Senior Securities**\n\n \n\nThe current portion of notes payable on the Company’s\nCondensed Consolidated Balance Sheets above contains, at March 31, 2026, certain promissory notes on which the Company was in arrears\non payments of principal as follows:\n\n \n\n●On November 25, 2019, the Company, pursuant to the certificate of designation of the Series BB Preferred\nStock, elected to exchange the preferred shares for other indebtedness calculated at a price per share equal to $1.20. Upon the Company’s\nmailing of the Exchange Agreement, the shareholder had the option, within 30 days of such mailing date to receive the indebtedness in\nthe form of a convertible note. If the shareholder did not give the Company notice, the indebtedness shall automatically be issued in\nthe form of a promissory note without any conversion feature. The promissory notes bear no interest and have a four (4) year maturity\ndate with a 20% premium to be paid upon maturity. The notes may be repaid in whole or in part at any time prior to maturity. As of December\n31, 2019, 276,723 Preferred Series BB shares were exchanged for an aggregate of $332,068 promissory notes. As of March 31, 2026, the aggregate\nloan balances were outstanding $398,482. This loan is currently in default.\n\n \n\n■On August 18, 2021, the Company entered into an unsecured promissory note in the amount of $400,000. Pursuant\nto the terms of the note, the investor shall receive the right to a perpetual 7.75% (payment percentage) of the revenues of Global Stem\nCell Group. As of March 31, 2026, the Company accrued $1,310,706 in interest expense. The note is currently in default due to the non-payment\nof interest.\n\n \n\n■On December 9, 2020, the Company entered into an unsecured promissory note in the amount of $110,000.\nPursuant to the terms of the note, the note bears fifteen (15%) interest, unsecured and is due on December 9, 2023. As of March 31, 2026,\nthe Company accrued $125,056 in interest expense. The note is currently in default\n\n \n\nPage **34** of **36**\n\n \n\n \n\n■On December 30, 2021, the Company entered into an unsecured promissory note in the amount of $7,958. Pursuant\nto the terms of the note, the note bears twelve (12%) interest, unsecured and is due on July 30, 2023. As of March 31, 2026, the Company\naccrued $4,951 in interest expense. The note is currently in default.\n\n \n\n■On December 30, 2021, the Company entered into an unsecured promissory note in the amount of $111,470.\nPursuant to the terms of the note, the note bears twelve (12%) interest, unsecured and is due on July 30, 2023. As of March 31, 2026,\nthe Company accrued $69,365 in interest expense. The note is currently in default.\n\n \n\nAt March 31, 2026, and December 31, 2025, none\nof these notes have been paid, but the Company has received no notice of default, demand for payment, or acceleration from any lender\nas of the date of this report. The Company has insufficient cash on hand to repay these notes. While management believes the risk of acceleration\nis low based on historical lender forbearance, a formal demand on any defaulted note could trigger acceleration of up to $16.6 million\nin secured debt. If we are unable to generate sufficient revenues and/or additional financing to service this debt, there is a risk the\nlenders will call the notes, secure our assets, as to those applicable secured notes, and demand payment. If this happens, we could go\nout of business."}